Temozolomide-induced inhibition of pituitary adenoma cells

O6-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas

(2009) Georg Widhalm et al.   CANCER

Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy

(2009) C Hagen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Radiosensitizing Effects of Temozolomide Observed in vivo only in a Subset of O6-Methylguanine-DNA Methyltransferase Methylated Glioblastoma Multiforme Xenografts

(2009) Brett L. Carlson et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS

(2009) Safraz Mohammed et al.   NEUROSURGERY

Multimodality Treatment for Invasive Pituitary Adenomas

(2009) Mark Hornyak et al.   POSTGRADUATE MEDICINE

In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide

(2008) W. J. Kil et al.   CLINICAL CANCER RESEARCH

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

(2008) Ann I. McCormack et al.   CLINICAL ENDOCRINOLOGY

Treatment of Nelson's syndrome with temozolomide

(2008) V J Moyes et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

(2008) Monika E. Hegi et al.   JOURNAL OF CLINICAL ONCOLOGY